Dobutamine-induced wall motion abnormalities: correlations with myocardial fractional flow reserve and quantitative coronary angiography

Cardiovascular Center, Aalst, Belgium.

OBJECTIVES: This study evaluated both the relation between dobutamine-induced wall motion abnormalities and the physiologic and morphologic features of epicardial coronary artery stenoses and the impact of the extent of the area at risk on the sensitivity of dobutamine echocardiography. BACKGROUND: The accuracy of dobutamine echocardiography has traditionally been assessed by comparing results with stenosis geometry. Myocardial fractional flow reserve is a functional index of coronary stenosis severity that takes into account both antero-grade and collateral flow and may therefore be a more appropriate standard for comparison. METHODS: Seventy-five patients with normal left ventricular function, good echocardiographic images and an isolated coronary stenosis underwent, within 6 h, dobutamine echocardiography, quantitative coronary angiography and intracoronary pressure measurements. Myocardial fractional flow reserve was calculated as the ratio of mean hyperemic distal coronary to aortic pressure. RESULTS: The degree of dobutamine-induced dyssynergy correlated significantly with percent diameter stenosis (r = 0.68), area stenosis (r = 0.68) and minimal lumen diameter (r = -0.60) and markedly better with myocardial fractional flow reserve (r = -0.77). However, marked dispersion of the individual data was observed. The sensitivity of dobutamine echocardiography in detecting lesions with a minimal lumen diameter < or = 1 mm and diameter stenosis > or = 50% was 83% and 80%, respectively. All but one patient with a myocardial fractional flow reserve >0.75 had a normal stress test result. Among patients with a myocardial fractional flow reserve < or = 0.75, the sensitivity of dobutamine echocardiography was significantly lower for lesions in vessels with a reference diameter < or = 2.6 mm than for lesions in larger vessels (58% vs. 90%, p = 0.008). CONCLUSIONS: 1) The magnitude of wall motion abnormalities induced by dobutamine infusion correlates with angiographic and, more closely, with functional indexes of stenosis severity, even though a wide scatter is observed. 2) In patients with a functionally significant stenosis, the amount of myocardium at risk is a critical determinant of the accuracy of dobutamine echocardiography.

This article has been cited by other articles:

				O. Muller and B. De Bruyne Chapter 9 Coronary physiology in clinical practice Oxford Textbook of Interventional Cardiology, January 1, 2010; 1(1): med-9780199569083-chapter - med-9780199569083-chapter. [Abstract] [Full Text]

				R. Gebker, C. Jahnke, R. Manka, A. Hamdan, B. Schnackenburg, E. Fleck, and I. Paetsch Additional Value of Myocardial Perfusion Imaging During Dobutamine Stress Magnetic Resonance for the Assessment of Coronary Artery Disease Circ Cardiovasc Imaging, September 1, 2008; 1(2): 122 - 130. [Abstract] [Full Text] [PDF]

				W. B. Meijboom, C. A.G. Van Mieghem, N. van Pelt, A. Weustink, F. Pugliese, N. R. Mollet, E. Boersma, E. Regar, R. J. van Geuns, P. J. de Jaegere, et al. Comprehensive Assessment of Coronary Artery Stenoses: Computed Tomography Coronary Angiography Versus Conventional Coronary Angiography and Correlation With Fractional Flow Reserve in Patients With Stable Angina J. Am. Coll. Cardiol., August 19, 2008; 52(8): 636 - 643. [Abstract] [Full Text] [PDF]

				S. Gang, M. Dabhi, and M. M. Rajapurkar Ischaemia imaging in type 2 diabetic kidney transplant candidates is coronary angiography essential? Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2334 - 2338. [Abstract] [Full Text] [PDF]

				T. H. Marwick Straining to detect ischaemia Eur. Heart J., June 6, 2007; (2007) ehm166v1. [Full Text] [PDF]

				J. Madaric, J. Bartunek, K. Verhamme, M. Penicka, E. Van Schuerbeeck, P. Nellens, G. R. Heyndrickx, W. Wijns, M. Vanderheyden, and B. De Bruyne Hyperdynamic Myocardial Response to Beta-Adrenergic Stimulation in Patients With Chest Pain and Normal Coronary Arteries J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1270 - 1275. [Abstract] [Full Text] [PDF]

				W. K. Hau Fractional flow reserve and complex coronary pathologic conditions Eur. Heart J., May 1, 2004; 25(9): 723 - 727. [Abstract] [Full Text] [PDF]

				J. L. Orford, A. Lerman, and D. R. Holmes Routine intravascular ultrasound guidance of percutaneous coronary intervention: A critical reappraisal J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1335 - 1342. [Abstract] [Full Text] [PDF]

				E. Barbato, J. Bartunek, E. Wyffels, W. Wijns, G. R. Heyndrickx, and B. De Bruyne Effects of intravenous dobutamineon coronary vasomotion in humans J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1596 - 1601. [Abstract] [Full Text] [PDF]

				M. J. Kern Dobutamine and the coronary vasomotion paradox J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1602 - 1604. [Full Text] [PDF]

				D. Brosh, S. T. Higano, M. J. Slepian, H. I. Miller, M. J. Kern, R. J. Lennon, D. R. Holmes Jr, and A. Lerman Pulse transmission coefficient: a novel nonhyperemic parameter for assessing the physiological significance of coronary artery stenoses J. Am. Coll. Cardiol., March 20, 2002; 39(6): 1012 - 1019. [Abstract] [Full Text] [PDF]

				B. De Bruyne, F. Hersbach, N. H.J. Pijls, J. Bartunek, J.-W. Bech, G. R. Heyndrickx, K. L. Gould, and W. Wijns Abnormal Epicardial Coronary Resistance in Patients With Diffuse Atherosclerosis but "Normal" Coronary Angiography Circulation, November 13, 2001; 104(20): 2401 - 2406. [Abstract] [Full Text] [PDF]

				B. De Bruyne, N. H.J. Pijls, J. Bartunek, K. Kulecki, J.-W. Bech, H. De Winter, P. Van Crombrugge, G. R. Heyndrickx, and W. Wijns Fractional Flow Reserve in Patients With Prior Myocardial Infarction Circulation, July 10, 2001; 104(2): 157 - 162. [Abstract] [Full Text] [PDF]

				B. De Bruyne, N. H. J. Pijls, G. R. Heyndrickx, D. Hodeige, R. Kirkeeide, and K. L. Gould Pressure-Derived Fractional Flow Reserve to Assess Serial Epicardial Stenoses : Theoretical Basis and Animal Validation Circulation, April 18, 2000; 101(15): 1840 - 1847. [Abstract] [Full Text] [PDF]

				A Franke, R Hoffmann, H P Kuhl, W Lepper, O A Breithardt, M Schormann, and P Hanrath Non-contrast second harmonic imaging improves interobserver agreement and accuracy of dobutamine stress echocardiography in patients with impaired image quality Heart, February 1, 2000; 83(2): 133 - 140. [Abstract] [Full Text]

				E G Zouridakis, I D Cox, X Garcia-Moll, S Brown, P Nihoyannopoulos, and J C Kaski Negative stress echocardiographic responses in normotensive and hypertensive patients with angina pectoris, positive exercise stress testing, and normal coronary arteriograms Heart, February 1, 2000; 83(2): 141 - 146. [Abstract] [Full Text]

				A. Takagi, Y. Tsurumi, Y. Ishii, K. Suzuki, M. Kawana, and H. Kasanuki Clinical Potential of Intravascular Ultrasound for Physiological Assessment of Coronary Stenosis : Relationship Between Quantitative Ultrasound Tomography and Pressure-Derived Fractional Flow Reserve Circulation, July 20, 1999; 100(3): 250 - 255. [Abstract] [Full Text] [PDF]

				B. D. Beleslin, M. Ostojic, A. Djordjevic-Dikic, R. Babic, M. Nedeljkovic, G. Stankovic, S. Stojkovic, J. Marinkovic, I. Nedeljkovic, J. Stepanovic, et al. Integrated evaluation of relation between coronary lesion features and stress echocardiography results: the importance of coronary lesion morphology J. Am. Coll. Cardiol., March 1, 1999; 33(3): 717 - 726. [Abstract] [Full Text] [PDF]

				E. Nagel, H. B. Lehmkuhl, W. Bocksch, C. Klein, U. Vogel, E. Frantz, A. Ellmer, S. Dreysse, and E. Fleck Noninvasive Diagnosis of Ischemia-Induced Wall Motion Abnormalities With the Use of High-Dose Dobutamine Stress MRI : Comparison With Dobutamine Stress Echocardiography Circulation, February 16, 1999; 99(6): 763 - 770. [Abstract] [Full Text] [PDF]

				N H J Pijls and B De Bruyne Coronary pressure measurement and fractional flow reserve Heart, December 1, 1998; 80(6): 539 - 542. [Full Text]

				I. Afridi, P. A. Grayburn, J. A. Panza, J. K. Oh, W. A. Zoghbi, and T. H. Marwick Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction J. Am. Coll. Cardiol., October 1, 1998; 32(4): 921 - 926. [Abstract] [Full Text] [PDF]

				H. A. Skopicki, S. A. Abraham, M. H. Picard, N. M. Alpert, A. J. Fischman, and H. Gewirtz Effects of Dobutamine at Maximally Tolerated Dose on Myocardial Blood Flow in Humans With Ischemic Heart Disease Circulation, November 18, 1997; 96(10): 3346 - 3352. [Abstract] [Full Text]